BIT — Biotron Income Statement
0.000.00%
Last trade - 00:00- AU$6.64m
- AU$5.70m
Annual income statement for Biotron, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.2 | 2.78 | 3.61 | 3.51 | 0.339 |
| Operating Profit | -3.2 | -2.78 | -3.61 | -3.51 | -0.339 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -3.19 | -2.78 | -3.49 | -3.44 | -0.319 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.19 | -2.78 | -3.49 | -3.44 | -0.319 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.19 | -2.78 | -3.49 | -3.44 | -0.319 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.19 | -2.78 | -3.49 | -3.44 | -0.319 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.004 | -0.003 | -0.004 | -0.003 | -0 |